These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 9949325)

  • 1. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
    Nakayama T; Aizawa C; Kuno-Sakai H
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):321-5. PubMed ID: 9949325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
    Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
    Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
    Pool V; Braun MM; Kelso JM; Mootrey G; Chen RT; Yunginger JW; Jacobson RM; Gargiullo PM;
    Pediatrics; 2002 Dec; 110(6):e71. PubMed ID: 12456938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy.
    Kuno-Sakai H; Kimura M
    Biologicals; 2003 Dec; 31(4):245-9. PubMed ID: 14624794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic allergic reactions to gelatin included in vaccines as a stabilizer.
    Sakaguchi M; Inouye S
    Jpn J Infect Dis; 2000 Oct; 53(5):189-95. PubMed ID: 11135703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines.
    Sakaguchi M; Inouye S
    Vaccine; 2000 Apr; 18(19):2055-8. PubMed ID: 10706969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin.
    Kelso JM; Jones RT; Yunginger JW
    J Allergy Clin Immunol; 1993 Apr; 91(4):867-72. PubMed ID: 8473675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China.
    Xu Y; Chen H; Wang B; Zhu X; Luo L; Wang S; Xiao Y; Wang H; Ma R; Liu S; Yan L; Li X; Chen D; Su Y; Chai Y; Fu J; Mao X; Cao J; Sun P; Tang F; Sun X; Wang Z; Yang X
    Int J Infect Dis; 2023 Dec; 137():9-15. PubMed ID: 37832931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines.
    Sakaguchi M; Nakayama T; Inouye S
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1058-61. PubMed ID: 8977505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
    Farrington P; Pugh S; Colville A; Flower A; Nash J; Morgan-Capner P; Rush M; Miller E
    Lancet; 1995 Mar; 345(8949):567-9. PubMed ID: 7619183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gelatin story.
    Kelso JM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):200-2. PubMed ID: 9949308
    [No Abstract]   [Full Text] [Related]  

  • 16. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.
    Daley MF; Yih WK; Glanz JM; Hambidge SJ; Narwaney KJ; Yin R; Li L; Nelson JC; Nordin JD; Klein NP; Jacobsen SJ; Weintraub E
    Vaccine; 2014 May; 32(25):3019-24. PubMed ID: 24699471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.